Opko Renal, LLC

United States of America

Back to Profile
1-6 of 6 for Opko Renal, LLC Sort by
Query
Aggregations
Date
2021 1
Before 2020 5
IPC Class
A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3 5
A61K 9/00 - Medicinal preparations characterised by special physical form 5
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate 5
A61K 31/592 - 9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2 4
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin 4
See more
Found results for  patents

1.

3

      
Application Number 17237889
Grant Number 11911398
Status In Force
Filing Date 2021-04-22
First Publication Date 2021-08-05
Grant Date 2024-02-27
Owner OPKO RENAL, LLC (USA)
Inventor
  • Bishop, Charles W.
  • Crawford, Keith H.
  • Messner, Eric J.

Abstract

3.

IPC Classes  ?

  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/592 - 9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

2.

Methods for controlled release oral dosage of a vitamin D compound

      
Application Number 15726046
Grant Number 11154509
Status In Force
Filing Date 2017-10-05
First Publication Date 2018-02-01
Grant Date 2021-10-26
Owner
  • EIRGEN PHARMA LTD. (Ireland)
  • OPKO RENAL, LLC (USA)
Inventor
  • Bishop, Charles W.
  • Tabash, Samir P.
  • Agudoawu, Sammy A.
  • White, Jay A.
  • Crawford, Keith H.
  • Messner, Eric J.
  • Petkovich, P. Martin

Abstract

A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation.

IPC Classes  ?

  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 47/06 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 31/59 - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
  • A61K 9/00 - Medicinal preparations characterised by special physical form

3.

3

      
Application Number 15722757
Grant Number 10213442
Status In Force
Filing Date 2017-10-02
First Publication Date 2018-01-25
Grant Date 2019-02-26
Owner OPKO RENAL, LLC (USA)
Inventor
  • Bishop, Charles W.
  • Crawford, Keith H.
  • Messner, Eric J.

Abstract

3.

IPC Classes  ?

  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/592 - 9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

4.

Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3

      
Application Number 14548275
Grant Number 09943530
Status In Force
Filing Date 2014-11-19
First Publication Date 2015-03-19
Grant Date 2018-04-17
Owner OPKO RENAL, LLC (USA)
Inventor
  • Bishop, Charles W.
  • Crawford, Keith H.
  • Messner, Eric J.

Abstract

3.

IPC Classes  ?

  • A61K 31/675 - Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
  • A61K 31/59 - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/592 - 9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

5.

Oral dosage form of 25-hydroxyvitamin D

      
Application Number 13848982
Grant Number 08906410
Status In Force
Filing Date 2013-03-22
First Publication Date 2013-09-12
Grant Date 2014-12-09
Owner
  • OPKO HEALTH, INC. (USA)
  • OPKO RENAL, LLC (USA)
Inventor
  • Bishop, Charles W.
  • Crawford, Keith H.
  • Messner, Eric J.

Abstract

3.

IPC Classes  ?

  • A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/592 - 9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

6.

3

      
Application Number 12278053
Grant Number 08426391
Status In Force
Filing Date 2007-02-02
First Publication Date 2009-12-17
Grant Date 2013-04-23
Owner
  • OPKO HEALTH, INC. (USA)
  • OPKO RENAL, LLC (USA)
Inventor
  • Bishop, Charles W.
  • Crawford, Keith H.
  • Messner, Eric J.

Abstract

3.

IPC Classes  ?

  • A01N 45/00 - Biocides, pest repellants or attractants, or plant growth regulators containing compounds having three or more carbocyclic rings condensed among themselves, at least one ring not being a six-membered ring
  • A61K 31/59 - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
  • A61K 38/37 - Factors VIII
  • A61K 9/52 - Sustained or differential release type
  • C07K 14/755 - Factors VIII